🇺🇸 FDA

Company profile · Sponsor

Merz

Merz Therapeutics GmbH

E015719 · EMA pharma EU
Pipeline
3
Drugs
0
Patents
0

Quick answer

Merz (E015719) is a pharma company. headquartered in EU. listed on EMA. NovaPharmaNews links 3 pipeline programs, 0 drugs, and 0 patents to this profile..

Company facts

Ticker E015719
Exchange EMA
Company type pharma
Headquarters EU

Pipeline (3)

Search pipeline →

  1. Bocouture, Placebo excipients (sucrose and human serum albumin) are reconstituted with sterile saline. Placebo vials will have identical appearance as the active product vials.

    Merz

    Moderate to Severe Platysma Prominence

    phase 3 small molecule active

    1 trial

  2. CLOSTRIDIUM BOTULINUM NEUROTOXIN TYPE A (150KD), FREE OF COMPLEXING PROTEINS, Placebo to Clostridium Botulinum neurotoxin type A (150 kD)

    Merz

    Episodic migraine

    phase 3 small molecule active

    1 trial

  3. Placebo to Clostridium Botulinum neurotoxin type A (150 kD), CLOSTRIDIUM BOTULINUM NEUROTOXIN TYPE A (150KD), FREE OF COMPLEXING PROTEINS

    Merz

    Chronic migraine

    phase 3 small molecule active

    1 trial

Frequently asked questions

What is Merz?

Merz (E015719) is a pharma company. headquartered in EU. listed on EMA. NovaPharmaNews links 3 pipeline programs, 0 drugs, and 0 patents to this profile..

What pipeline programs does Merz sponsor?

We track 3 ClinicalTrials.gov-linked programs for Merz, including Bocouture, Placebo excipients (sucrose and human serum albumin) are reconstituted with sterile saline. Placebo vials will have identical appearance as the active product vials. and 2 more. Open each program for phase, modality, NCT IDs, and indication details.

Where does Merz company data come from?

Profiles combine SEC EDGAR (CIK/ticker), ClinicalTrials.gov sponsor links, FDA drug records, and USPTO patent metadata. See our data sources page. This profile is for professional reference, not investment advice.